Updated: May 10, 2026

Preparation of rAAV9 to Overexpress or Knockdown Genes in Mouse Hearts
Published on: December 17, 2016
Guo-Hai Zhang1, Shu-Lan Zeng, Rui-An Xu
1State Key Laboratory Cultivation Base for the Chemistry and Molecular Engineering of Medicinal Resources, Guangxi Normal University, Guilin 541004, China.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Reducing immune responses to adeno-associated virus (AAV) gene therapy is crucial. Strategies focus on optimizing AAV administration, vector design, and promoter selection to maintain efficacy while lowering vector dosage.
Area of Science: